All Stories

  1. Gene therapy in hemophilia: the dawn of a new era

    Article • Research and Practice in Thrombosis and Haemostasis, November 2024, Elsevier

    Dr Roberta Gualtierotti

  2. Exploring the Impact of Sex and Gender in Brain Function: Implications and Considerations

    Article • Advances in Therapy, October 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  3. Fibro-adhesive Bursitis: A Novel Sonographic Finding in Adhesive Capsulitis Patients and a Proposal of Management

    Article • Rheumatology and Therapy, September 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  4. Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life

    Article • Journal of Clinical Medicine, August 2024, MDPI AG

    Dr Roberta Gualtierotti

  5. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology

    Article • Journal of Thrombosis and Haemostasis, June 2024, Elsevier

    Dr Roberta Gualtierotti

  6. Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19

    Article • Internal and Emergency Medicine, May 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  7. Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging

    Article • Haemophilia, May 2024, Wiley

    Dr Roberta Gualtierotti

  8. Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis

    Article • Blood Advances, March 2024, American Society of Hematology

    Dr Roberta Gualtierotti

  9. Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome

    Article • Haemophilia, February 2024, Wiley

    Dr Roberta Gualtierotti

  10. Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A

    Article • Blood Advances, October 2023, American Society of Hematology

    Dr Roberta Gualtierotti

  11. Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia

    Article • Journal of Clinical Medicine, October 2023, MDPI AG

    Dr Roberta Gualtierotti

  12. Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study

    Article • Journal of Clinical Medicine, August 2023, MDPI AG

    Dr Roberta Gualtierotti

  13. Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy.

    Article • Blood Advances, July 2023, American Society of Hematology

    Dr Roberta Gualtierotti

  14. Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients

    Article • Journal of Clinical Medicine, May 2023, MDPI AG

    Dr Roberta Gualtierotti

  15. Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination

    Article • Blood Advances, October 2022, American Society of Hematology

    Dr Roberta Gualtierotti

  16. Updates on Novel Non-Replacement Drugs for Hemophilia

    Article • Pharmaceuticals, September 2022, MDPI AG

    Dr Roberta Gualtierotti

  17. Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit

    Article • Journal of Clinical Medicine, September 2022, MDPI AG

    Dr Roberta Gualtierotti

  18. Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report

    Article • Rheumatology and Therapy, August 2022, Springer Science + Business Media

    Dr Roberta Gualtierotti

  19. Play4Physio: Supporting Physical Therapy of Children with Hemophilia

    Article • June 2022, ACM (Association for Computing Machinery)

    Dr Roberta Gualtierotti, Dragan Ahmetovic

  20. A Response to: Letter to the Editor Regarding Ultrasound Features of Adhesive Capsulitis

    Article • Rheumatology and Therapy, May 2022, Springer Science + Business Media

    Dr Roberta Gualtierotti

  21. Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy

    Article • Pain and Therapy, January 2022, Springer Science + Business Media

    Dr Roberta Gualtierotti

  22. Ultrasound Features of Adhesive Capsulitis

    Article • Rheumatology and Therapy, December 2021, Springer Science + Business Media

    Dr Roberta Gualtierotti

  23. Hemophilic arthropathy: Current knowledge and future perspectives

    Article • Journal of Thrombosis and Haemostasis, July 2021, Wiley

    Dr Roberta Gualtierotti

  24. The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians

    Article • Journal of Clinical Medicine, October 2020, MDPI AG

    Dr Roberta Gualtierotti

  25. Hemostatic alterations in COVID-19

    Article • Haematologica, August 2020, Ferrata Storti Foundation (Haematologica)

    Dr Roberta Gualtierotti

  26. Inflammatory interactions between degenerated intervertebral discs and microglia: implication of sphingosine‐1‐phosphate signalling

    Article • Journal of Orthopaedic Research®, August 2020, Wiley

    Dr Roberta Gualtierotti

  27. Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study

    Article • Journal of Clinical Medicine, July 2020, MDPI AG

    Dr Roberta Gualtierotti

  28. Hereditary Deficiency of the Second Component of Complement: Early Diagnosis and 21-Year Follow-Up of a Family

    Article • Medicina, March 2020, MDPI AG

    Dr Roberta Gualtierotti

  29. IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data

    Article • Proceedings, December 2019, MDPI AG

    Dr Roberta Gualtierotti, Professor Marco De Andrea

  30. Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis

    Article • Advances in Therapy, October 2019, Springer Science + Business Media

    Dr Roberta Gualtierotti

  31. Fibromyalgia and Shoulder Surgery: A Systematic Review and a Critical Appraisal of the Literature

    Article • Journal of Clinical Medicine, September 2019, MDPI AG

    Dr Roberta Gualtierotti

  32. Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune Diseases

    Article • Journal of Clinical Medicine, August 2019, MDPI AG

    Dr Roberta Gualtierotti

  33. Efficacy and Metabolic Effect on Serum Lipids of Apremilast in Psoriatic Arthritis: A Case Report

    Article • Journal of Clinical Medicine, March 2019, MDPI AG

    Dr Roberta Gualtierotti

  34. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus

    Article • Journal of Experimental Medicine, January 2019, Rockefeller University Press

    Dr Roberta Gualtierotti

  35. Vitamin D and Anti-Phospholipid Antibody Syndrome: A Comprehensive Review

    Article • The Open Rheumatology Journal, December 2018, Bentham Science Publishers

    Dr Roberta Gualtierotti

  36. Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases

    Article • Journal of Clinical Medicine, December 2018, MDPI AG

    Dr Roberta Gualtierotti

  37. Total Joint Arthroplasty in Patients with Inflammatory Rheumatic Diseases

    Article • Advances in Therapy, July 2018, Springer Science + Business Media

    Dr Roberta Gualtierotti

  38. The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts

    Article • Medicine, April 2018, Wolters Kluwer Health

    Dr Roberta Gualtierotti

  39. Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview

    Article • Advances in Therapy, March 2018, Springer Science + Business Media

    Dr Roberta Gualtierotti

  40. Detection of early endothelial damage in patients with Raynaud's phenomenon

    Article • Microvascular Research, September 2017, Elsevier

    Dr Roberta Gualtierotti

  41. Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis

    Article • Rheumatology and Therapy, July 2017, Springer Science + Business Media

    Dr Roberta Gualtierotti

  42. Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review

    Article • Clinical Reviews in Allergy & Immunology, July 2017, Springer Science + Business Media

    Dr Roberta Gualtierotti

  43. Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids

    Article • Advances in Therapy, January 2017, Springer Science + Business Media

    Dr Roberta Gualtierotti

  44. Understanding cardiovascular risk in rheumatoid arthritis: Still a long way to go

    Article • Atherosclerosis, January 2017, Elsevier

    Dr Roberta Gualtierotti

  45. Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis

    Article • Swiss Medical Weekly, December 2016, EMH Swiss Medical Publishers, Ltd.

    Dr Roberta Gualtierotti

  46. Health-Related Quality of Life in Systemic Sclerosis: Feasibility and Construct Validity of Eq-5d

    Article • Value in Health, November 2016, Elsevier

    Dr Roberta Gualtierotti

  47. The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling

    Article • Stem Cells and Development, July 2016, Mary Ann Liebert Inc

    Dr Roberta Gualtierotti

  48. Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes

    Article • Mediators of Inflammation, January 2016, Hindawi Publishing Corporation

    Dr Roberta Gualtierotti

  49. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study

    Article • Microvascular Research, November 2015, Elsevier

    Dr Roberta Gualtierotti

  50. Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds

    Article • Organogenesis, October 2015, Taylor & Francis

    Dr Roberta Gualtierotti

  51. Corrigendum to ‘Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapy’ [Autoimmun Rev 13/1 (2014) p.40–48]

    Article • Autoimmunity Reviews, July 2015, Elsevier

    Dr Roberta Gualtierotti

  52. AB1085 Empirical Approach to Investigate Raynaud's Phenomenon: The Pearl Study

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Dr Roberta Gualtierotti

  53. OP0221 Nailfold Capillaroscopy Patterns in Adulthood are Similar in Patients with Juvenile and Adult-Onset Systemic Sclerosis: A Eustar Case-Control Study

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Dr Roberta Gualtierotti

  54. Sparing effect of hemiplegia on skin fibrosis and microvascular involvement: Reports of two cases of systemic sclerosis and review of the literature

    Article • Seminars in Arthritis and Rheumatism, April 2015, Elsevier

    Dr Roberta Gualtierotti

  55. Gene Expression Profile Analysis of Human Mesenchymal Stem Cells from Herniated and Degenerated Intervertebral Discs Reveals Different Expression of Osteopontin

    Article • Stem Cells and Development, February 2015, Mary Ann Liebert Inc

    Dr Roberta Gualtierotti

  56. Choroidal impairment and macular thinning in patients with systemic sclerosis: The acute study

    Article • Microvascular Research, January 2015, Elsevier

    Dr Roberta Gualtierotti

  57. Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud’s Phenomenon

    Article • Journal of Immunology Research, January 2015, Hindawi Publishing Corporation

    Dr Roberta Gualtierotti

  58. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome

    Article • Journal of Thrombosis and Haemostasis, September 2014, Elsevier

    Massimo Cugno, Dr Roberta Gualtierotti

  59. AB1013 Systemic Sclerosis and Myositis Extractable Nuclear Antigen (ENA) Analysis: Profile of A Cohort of Subjects with Isolated Raynaud's Phenomenon

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr Roberta Gualtierotti

  60. Authors’ Reply to Verdelli et al.: There Is No Knowledge Without Experience

    Article • Clinical Drug Investigation, May 2014, Springer Science + Business Media

    Dr Roberta Gualtierotti

  61. Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk

    Article • Expert Review of Clinical Immunology, January 2014, Taylor & Francis

    Dr Roberta Gualtierotti

  62. Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapy

    Article • Autoimmunity Reviews, January 2014, Elsevier

    Dr Roberta Gualtierotti

  63. Rheumatoid Factors

    Article • January 2014, Elsevier

    Dr Roberta Gualtierotti

  64. Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?

    Article • Annals of the Rheumatic Diseases, December 2013, BMJ

    Dr Roberta Gualtierotti

  65. Choosing treatment options for patients with relapsed/refractory multiple myeloma

    Article • Expert Review of Anticancer Therapy, December 2013, Taylor & Francis

    Dr Roberta Gualtierotti

  66. Is it safe to withdraw etanercept in established rheumatoid arthritis after low disease activity achievement?

    Article • Internal and Emergency Medicine, December 2013, Springer Science + Business Media

    Dr Roberta Gualtierotti

  67. Tocilizumab Monotherapy in a Patient with Rheumatoid Arthritis and Iatrogenic Kaposi Sarcoma

    Article • Clinical Drug Investigation, December 2013, Springer Science + Business Media

    Dr Roberta Gualtierotti

  68. Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria

    Article • Expert Opinion on Pharmacotherapy, November 2013, Informa Healthcare

    Dr Roberta Gualtierotti

  69. A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis

    Article • Expert Review of Clinical Immunology, November 2013, Taylor & Francis

    Dr Roberta Gualtierotti

  70. Nailfold capillary patterns in healthy subjects: A real issue in capillaroscopy

    Article • Microvascular Research, November 2013, Elsevier

    Dr Roberta Gualtierotti

  71. Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients

    Article • Expert Opinion on Pharmacotherapy, July 2013, Informa Healthcare

    Dr Roberta Gualtierotti

  72. SAT0214 Reliability and Validity of the Italian Version of the Ucla-Scleroderma Clinical Trial Consortium-Gastrointestinal Tract Instrument in Patients with Systemic Sclerosis

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Andrea Becciolini, Dr Roberta Gualtierotti

  73. AB0830 Role of anti-IFI16 antibodies and NT-PROBNP as candidate biomarkers in systemic sclerosis

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Roberta Gualtierotti

  74. FRI0402 Vascular changes in choroid plexus in patients with raynaud’s phenomenon suspected secondary to a connective tissue disease

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Roberta Gualtierotti

  75. FRI0403 How early starts increased collagen synthesis in systemic sclerosis?

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Roberta Gualtierotti

  76. SAT0401 The nailfold capillary patterns in healthy subjects: A two center study

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Roberta Gualtierotti

  77. Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al.

    Article • Clinical Rheumatology, May 2013, Springer Science + Business Media

    Dr Roberta Gualtierotti

  78. An overlooked cause of back pain and stiffness

    Article • Rheumatology, January 2013, Oxford University Press (OUP)

    Dr Roberta Gualtierotti

  79. Current and Emerging Treatment Options for Patients with Relapsed Myeloma

    Article • Clinical Medicine Insights Oncology, January 2013, SAGE Publications

    Dr Roberta Gualtierotti

  80. Rheumatoid Factors: Clinical Applications

    Article • Disease Markers, January 2013, Hindawi Publishing Corporation

    Dr Roberta Gualtierotti

  81. Rheumatoid Nodules Predating Seroconversion and Rheumatoid Arthritis: An Uncommon Case Report

    Article • Journal of Clinical & Cellular Immunology, January 2013, OMICS Publishing Group

    Dr Roberta Gualtierotti

  82. The Role of Ultrasonography in the Assessment of Skeletal Hand Involvement in Systemic Sclerosis

    Article • Journal of Medical Ultrasound, December 2011, Medknow

    Dr Roberta Gualtierotti

  83. Nailfold capillaroscopic report: qualitative and quantitative methods

    Article • Reumatismo, September 2011, PAGEPress Publications

    Dr Roberta Gualtierotti

  84. Health related quality of life assessment in patients with systemic sclerosis

    Article • Reumatismo, June 2011, PAGEPress Publications

    Dr Roberta Gualtierotti

  85. Cutting-Edge Issues in Coronary Disease and the Primary Antiphospholipid Syndrome

    Article • Clinical Reviews in Allergy & Immunology, March 2011, Springer Science + Business Media

    Dr Roberta Gualtierotti

  86. Updating on the pathogenesis of systemic lupus erythematosus

    Article • Autoimmunity Reviews, November 2010, Elsevier

    Dr Roberta Gualtierotti

  87. Hand impairment in systemic sclerosis: association of different hand indices with organ involvement

    Article • Scandinavian Journal of Rheumatology, May 2010, Taylor & Francis

    Dr Roberta Gualtierotti

  88. Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis

    Article • Current Vascular Pharmacology, March 2010, Bentham Science Publishers

    Dr Roberta Gualtierotti

  89. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy

    Article • Rheumatology, January 2010, Oxford University Press (OUP)

    Dr Roberta Gualtierotti

  90. Feasibility of Different Capillaroscopic Measures for Identifying Nailfold Microvascular Alterations

    Article • Seminars in Arthritis and Rheumatism, February 2009, Elsevier

    Dr Roberta Gualtierotti

  91. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (Prognostic Index for Nailfold Capillaroscopic Examination)

    Article • Arthritis & Rheumatism, July 2008, Wiley

    Dr Roberta Gualtierotti

  92. Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis

    Article • Clinical Rheumatology, November 2007, Springer Science + Business Media

    Dr Roberta Gualtierotti